ph3Senior Group Director – Safety Development Processes /h3pSenior Group Director of Safety Development Processes (SDP) provides strategic leadership, expertise and oversight for a global team in the design, development, implementation and coordination of activities relating to safety development, innovation, process design and continuous improvement, on behalf of PDS. As a member of the PVSD Leadership Team, the Senior Group Director leads the global SDP function across four global product development sites: Basel (Switzerland), South San Francisco (USA), Welwyn (UK) and Mississauga (Canada). The role ensures that safety‑critical processes are designed, developed, ‘owned’ and supported in line with business requirements and continuous improvement goals. /ph3Key Responsibilities /h3ulliLead the global SDP sub‑function and coach team members to maximise potential and well‑being while sustaining a climate of purpose and urgency. /liliDefine and articulate vision and strategy for SDP, aligning with PVSD, PDS and broader enterprise strategies. /liliPartner closely with functions in RD and other stakeholders to anticipate and deliver improved scientific ways of working and effective safety processes. /liliRepresent SDP on compliance governance bodies (e.g., GxP Council) if required. /liliOversee recruitment, onboarding and deployment of SDP resources across multiple locations based on prioritised business needs. /liliMaintain relationships with key RD stakeholders and contribute to PVSD leadership in scenario planning, prioritisation and budget management. /liliDrive continuous improvement of safety processes in compliance with GVP, GCP and medical device domains. /liliCoordinate strategic and continuous improvement activities to advance PDS short‑ and long‑term objectives. /liliFacilitate safety innovation in coordination with process needs and provide niche scientific expertise to benefit the portfolio. /li /ulh3SDP Team Remit /h3ulliDesign, development, maintenance, oversight and continuous improvement of safety processes in compliance with GVP, GCP and medical device domains. /liliEnsure the organisation’s ability to execute safety processes through provision of technical and scientific expertise. /liliDevelop, implement and coordinate strategic and continuous improvement activities that advance PDS short‑ and long‑term objectives. /liliFacilitate and coordinate safety innovation in cohesion with the needs of the safety processes. /liliProvide niche scientific expertise that benefits the portfolio. /li /ulh3Candidate Profile /h3pYou are a highly developed senior leader with proven ability to lead global line‑ or matrix‑teams. You hold an advanced degree in a directly relevant discipline, or are a qualified health professional (MD, PharmD, etc.), supported by at least 10+ years of experience in patient safety/pharmacovigilance, typically gained via a senior role in the biopharmaceutical industry or a regulatory authority. A post‑graduate qualification in PV (e.g., PV Diploma or MSc) and/or business improvement or innovation (e.g., MBA; Lean Sigma certification) is desirable. You have significant business experience in areas directly relevant to patient safety, pharmacovigilance, clinical development, medical devices, business performance management, strategic business analysis, process management and/or closely related disciplines. You possess analytical thinking to design, implement, review and deliver complex cross‑functional processes, metrics and management information systems. You utilise highly developed communication and influencing skills to build global collaborations and drive decisions. /ph3Location Travel /h3pThis position must be based in either Basel, Switzerland or Welwyn Garden City, UK. Although it can be a hybrid role, there is an expectation of ongoing and sustained site presence in compliance with local company site requirements. International business travel may be required, typically around 15% of the time. /ph3Equal Opportunity Statement /h3pRoche is an Equal Opportunity Employer. We commit ourselves to scientific rigor, unassailable ethics, and access to medical innovations for all. /p /p #J-18808-Ljbffr
